[Therapy of parkinsonian syndromes with L-dopa. Results and prospects].
D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy* / Q000209:etiology; D010301:Parkinson Disease, Postencephalitic / Q000188:drug therapy; D010302:Parkinson Disease, Secondary / Q000139:chemically induced
D004295:Dihydroxyphenylalanine
La terapia delle sindromi parkinsoniane con L-dopa. Risultati e prospettive.